tailieunhanh - Comparison of resource use by COPD patients on inhaled therapies with long-acting bronchodilators: A database study

The purpose of this analysis was to compare health care costs and utilization among COPD patients who had long-acting beta-2 agonist (LABA) OR long-acting muscarinic antagonist (LAMA); LABA AND LAMA; or LABA, LAMA, AND inhaled corticosteroid (ICS) prescription claims. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN